https://orcid.org/0000-0002-7139-062X
Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nicholas C. Borgogna, Tyler Owen, Jacob Vaughn, David A. L. Johnson, Stephen L. Aita & Benjamin D. Hill. (2024) So how special is special K? A systematic review and meta-analysis of ketamine for PTSD RCTs. European Journal of Psychotraumatology 15:1.
Read now
Read now
Almira Osmanovic Thunström, Iris Sarajlic Vukovic, Lilas Ali, Tomas Larson & Steinn Steingrimsson. (2022) Prevalence of virtual reality (VR) games found through mental health categories on STEAM: a first look at VR on commercial platforms as tools for therapy. Nordic Journal of Psychiatry 76:6, pages 474-485.
Read now
Read now
Lynnette A. Averill & Chadi G. Abdallah. (2022) Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine. Expert Opinion on Investigational Drugs 31:2, pages 133-137.
Read now
Read now
Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal & Jessica L. Barrington-Trimis. Psychedelic Microdosing among Young Adults from Southern California. Journal of Psychoactive Drugs 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (18)
Julia Colcott, Alexandre A. Guerin, Olivia Carter, Sally Meikle & Gillinder Bedi. (2024) Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis. Neuropsychopharmacology.
Crossref
Crossref
Lisa Burback, Suzette Brémault-Phillips, Mirjam J. Nijdam, Alexander McFarlane & Eric Vermetten. (2024) Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review. Current Neuropharmacology 22:4, pages 557-635.
Crossref
Crossref
Nadeen Smaik, Leigh Ann Simmons, Bayan Abdulhaq & Latefa Ali Dardas. (2023) The feasibility and preliminary efficacy of narrative exposure therapy on post-traumatic stress disorder among Syrian refugees in Jordan. International Journal of Nursing Sciences 10:4, pages 518-526.
Crossref
Crossref
Marilyn Naeem, Alexander N. Le, Barbara E. Bauer, Andrew R. Chadeayne, James A. Golen & David R. Manke. (2023)
N
-Cyclohexyltryptamine: freebase, bromide and fumarate
. Acta Crystallographica Section E Crystallographic Communications 79:8, pages 752-756.
Crossref
Crossref
Iga Adamska & Karolina Finc. (2023) Effect of LSD and music on the time-varying brain dynamics. Psychopharmacology 240:7, pages 1601-1614.
Crossref
Crossref
Steve Kisely, Mark Connor, Andrew A Somogyi & Dan Siskind. (2022) A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Australian & New Zealand Journal of Psychiatry 57:3, pages 362-378.
Crossref
Crossref
Nadiia Omelchenko & Anton Kurapov. (2023) Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change. Bulletin of Taras Shevchenko National University of Kyiv. Psychology:1 (17), pages 56-64.
Crossref
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process
207
338
.
Thaís Rodrigues de Albuquerque, Luis Fernando Reis Macedo, Gyllyandeson de Araújo Delmondes, Modesto Leite Rolim Neto, Thales Marcon Almeida, Ricardo Riyoiti Uchida, Quirino Cordeiro, Kenya Waléria de Siqueira Coelho Lisboa & Irwin Rose Alencar de Menezes. (2022) Evidence for the beneficial effect of ketamine in the treatment of patients with post-traumatic stress disorder: A systematic review and meta-analysis. Journal of Cerebral Blood Flow & Metabolism 42:12, pages 2175-2187.
Crossref
Crossref
Jadon Webb & Shannon Keane. (2022) MDMA for the treatment of misophonia, a proposal. Frontiers in Psychiatry 13.
Crossref
Crossref
Laura A. Bajor, Charmi Balsara & David N. Osser. (2022) An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update. Psychiatry Research 317, pages 114840.
Crossref
Crossref
Robert J. Sottile & Thomas Vida. (2022) A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy. Frontiers in Psychiatry 13.
Crossref
Crossref
Raúl López-Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal-Gratacós, Pol Puigseslloses, María Espinosa-Velasco, Edurne Urquizu, Elena Escubedo & David Pubill. (2022) 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Frontiers in Psychiatry 13.
Crossref
Crossref
H. Bottemanne, A. Baldacci, C. Muller, A. Boyreau & A. Claret. (2022) Psychothérapie augmentée par la kétamine (KAP) dans les troubles de l’humeur : mode d’emploi. L'Encéphale 48:3, pages 304-312.
Crossref
Crossref
Kimberly W. Smith, Dakota J. Sicignano, Adrian V. Hernandez & C. Michael White. (2021) MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis. The Journal of Clinical Pharmacology 62:4, pages 463-471.
Crossref
Crossref
FL Smith, JC Neill & V Wainwright. (2022) An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma. Drug Science, Policy and Law 8, pages 205032452211241.
Crossref
Crossref
Nikki Coleman. 2022. Health Care in Contexts of Risk, Uncertainty, and Hybridity. Health Care in Contexts of Risk, Uncertainty, and Hybridity
221
234
.
C. J. Healy, Kellie Ann Lee & Wendy D’Andrea. (2021) Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment. Chronic Stress 5, pages 247054702110298.
Crossref
Crossref